Page 56 - 南京医科大学自然版
P. 56

第44卷第12期
               ·1670 ·                           南 京    医 科 大 学 学         报                        2024年12月


             [6] CHEN Y,QIN Y,DAI M M,et al. IBSP,a potential recur⁃  [15]FISHER L W,JAIN A,TAYBACK M,et al. Small integ⁃
                   rence biomarker,promotes the progression of colorectal  rin binding ligand N⁃linked glycoprotein gene family ex⁃
                   cancer via Fyn/β ⁃ catenin signaling pathway[J]. Cancer  pression in different cancers[J]. Clin Cancer Res,2004,
                   Med,2021,10(12):4030-4045                         10(24):8501-8511
             [7] WU K R,FENG J M,LYU F,et al. Exosomal miR⁃19a  [16]NAM J S,SUCHAR A M,KANG M J,et al. Bone sialopro⁃
                   and IBSP cooperate to induce osteolytic bone metastasis  tein mediates the tumor cell⁃targeted prometastatic activi⁃
                   of estrogen receptor⁃positive breast cancer[J]. Nat Com⁃  ty of transforming growth factor beta in a mouse model of
                   mun,2021,12(1):5196                               breast cancer[J]. Cancer Res,2006,66(12):6327-6335
             [8] DING W,LV D,WANG M S,et al. IBSP promotes breast  [17]WANG M Y,LIU B X,LI D,et al. Upregulation of IBSP
                   cancer bone metastasis and proliferation via BMP⁃SMAD  expression predicts poor prognosis in patients with
                   signaling pathway[J]. Cancer Rep,2024,7(8):e2153  esophageal squamous cell carcinoma[J]. Front Oncol,
             [9] ZENG A L,WEI Z Y,YAN W,et al. Exosomal transfer of  2019,9:1117
                   miR⁃151a enhances chemosensitivity to temozolomide in  [18]GHOCHANI Y,MUTHUKRISHNAN S D,SOHRABI A,
                   drug⁃resistant glioblastoma[J]. Cancer Lett,2018,436:  et al. A molecular interactome of the glioblastoma perivas⁃
                   10-21                                             cular niche reveals integrin binding sialoprotein as a me⁃
             [10] PAWLOWSKI K D,DUFFY J T,BABAK M V,et al.           diator of tumor cell migration[J]. Cell Rep,2022,41(3):
                   Modeling glioblastoma complexity with organoids for  111511
                   personalized treatments[J]. Trends Mol Med,2023,29  [19]ZHANG Q,LENARDO M J,BALTIMORE D. 30 years of
                  (4):282-296                                        NF⁃κB:a blossoming of relevance to human pathobiolo⁃
             [11]FILLEY A C,HENRIQUEZ M,DEY M. Recurrent glioma      gy[J]. Cell,2017,168(1/2):37-57
                   clinical trial,CheckMate⁃143:the game is not over yet[J].  [20]SUN S C. The non⁃canonical NF⁃κB pathway in immunity
                   Oncotarget,2017,8(53):91779-91794                 and inflammation[J]. Nat Rev Immunol,2017,17:545-558
             [12]张    伟,王   政. 中国抗癌协会脑胶质瘤整合诊治指南                 [21]TANIGUCHI K,KARIN M. NF⁃κB,inflammation,immu⁃
                  (精简版)[J]. 中国肿瘤临床,2022,49(16):811-818               nity and cancer:coming of age[J]. Nat Rev Immunol,
             [13] LAMOUR V,NOKIN M J,HENRY A,et al. SIBLING          2018,18(5):309-324
                   proteins:molecular tools for tumor progression and angio⁃  [22] XIAO F,ZHU H,XIONG Y P,et al. Positive feedback
                   genesis[J]. Med Sci,2013,29(11):1018-1025         loop of c⁃myc/XTP6/NDH2/NF⁃κB to promote malignant
             [14] FISHER L W,FEDARKO N S. Six genes expressed in     progression in glioblastoma[J]. J Exp Clin Cancer Res,
                   bones and teeth encode the current members of the SIB⁃  2024,43(1):187
                   LING family of proteins[J]. Connect Tissue Res,2003,                   [收稿日期] 2024-09-04
                   44(Suppl 1):33-40                                                          (本文编辑:蒋       莉)
   51   52   53   54   55   56   57   58   59   60   61